drugset / Trial / NCT00316992
Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine if ramelteon has respiratory depressant effects in subjects with moderate to severe chronic obstructive pulmonary disease.
Timeline
- Start
- 2006-04
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 8 mg | Oral |